nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—bile duct cancer	0.718	0.836	CbGaD
Acetylsalicylic acid—PTGS2—bile duct cancer	0.14	0.164	CbGaD
Acetylsalicylic acid—TP53—gall bladder—bile duct cancer	0.0059	0.131	CbGeAlD
Acetylsalicylic acid—NFKBIA—gall bladder—bile duct cancer	0.00581	0.129	CbGeAlD
Acetylsalicylic acid—TP53—pancreas—bile duct cancer	0.00272	0.0606	CbGeAlD
Acetylsalicylic acid—NFKBIA—pancreas—bile duct cancer	0.00268	0.0596	CbGeAlD
Acetylsalicylic acid—HSPA5—pancreas—bile duct cancer	0.00262	0.0584	CbGeAlD
Acetylsalicylic acid—RPS6KA3—pancreas—bile duct cancer	0.00223	0.0497	CbGeAlD
Acetylsalicylic acid—ALB—gall bladder—bile duct cancer	0.00209	0.0465	CbGeAlD
Acetylsalicylic acid—TP53—liver—bile duct cancer	0.00173	0.0385	CbGeAlD
Acetylsalicylic acid—NFKBIA—liver—bile duct cancer	0.0017	0.0379	CbGeAlD
Acetylsalicylic acid—HSPA5—liver—bile duct cancer	0.00167	0.0371	CbGeAlD
Acetylsalicylic acid—RPS6KA3—liver—bile duct cancer	0.00142	0.0316	CbGeAlD
Acetylsalicylic acid—TP53—lymph node—bile duct cancer	0.00133	0.0295	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—bile duct cancer	0.00131	0.0291	CbGeAlD
Acetylsalicylic acid—HSPA5—lymph node—bile duct cancer	0.00128	0.0285	CbGeAlD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—bile duct cancer	0.00124	0.338	CrCbGaD
Acetylsalicylic acid—PTGS2—gall bladder—bile duct cancer	0.00114	0.0253	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymph node—bile duct cancer	0.00109	0.0242	CbGeAlD
Acetylsalicylic acid—IKBKB—liver—bile duct cancer	0.00105	0.0233	CbGeAlD
Acetylsalicylic acid—SLC22A7—liver—bile duct cancer	0.00102	0.0226	CbGeAlD
Acetylsalicylic acid—EDNRA—lymph node—bile duct cancer	0.000885	0.0197	CbGeAlD
Acetylsalicylic acid—IKBKB—lymph node—bile duct cancer	0.000804	0.0179	CbGeAlD
Acetylsalicylic acid—Salsalate—PTGS2—bile duct cancer	0.000723	0.197	CrCbGaD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—bile duct cancer	0.000713	0.194	CrCbGaD
Acetylsalicylic acid—ALB—liver—bile duct cancer	0.000612	0.0136	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—PTGS2—bile duct cancer	0.000554	0.151	CrCbGaD
Acetylsalicylic acid—PTGS2—pancreas—bile duct cancer	0.000524	0.0117	CbGeAlD
Acetylsalicylic acid—CYP2C19—liver—bile duct cancer	0.000493	0.011	CbGeAlD
Acetylsalicylic acid—ALB—lymph node—bile duct cancer	0.000469	0.0104	CbGeAlD
Acetylsalicylic acid—Salicylic acid—PTGS2—bile duct cancer	0.000445	0.121	CrCbGaD
Acetylsalicylic acid—CYP2C8—liver—bile duct cancer	0.00043	0.00958	CbGeAlD
Acetylsalicylic acid—CYP2C9—liver—bile duct cancer	0.000382	0.00851	CbGeAlD
Acetylsalicylic acid—PTGS2—liver—bile duct cancer	0.000333	0.00742	CbGeAlD
Acetylsalicylic acid—ABCB1—pancreas—bile duct cancer	0.000324	0.00722	CbGeAlD
Acetylsalicylic acid—PTGS1—lymph node—bile duct cancer	0.000267	0.00595	CbGeAlD
Acetylsalicylic acid—PTGS2—lymph node—bile duct cancer	0.000256	0.00569	CbGeAlD
Acetylsalicylic acid—ABCB1—liver—bile duct cancer	0.000206	0.00459	CbGeAlD
Acetylsalicylic acid—ABCB1—lymph node—bile duct cancer	0.000158	0.00352	CbGeAlD
Acetylsalicylic acid—RPS6KA3—Axon guidance—IL6—bile duct cancer	4.8e-05	0.000517	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—HRAS—bile duct cancer	4.8e-05	0.000517	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—BDNF signaling pathway—HRAS—bile duct cancer	4.78e-05	0.000514	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—bile duct cancer	4.76e-05	0.000513	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—bile duct cancer	4.7e-05	0.000506	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—EGFR—bile duct cancer	4.67e-05	0.000502	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—FAR2—bile duct cancer	4.66e-05	0.000501	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll-Like Receptors Cascades—IL6—bile duct cancer	4.65e-05	0.0005	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TGFB1—bile duct cancer	4.65e-05	0.0005	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—NRAS—bile duct cancer	4.64e-05	0.0005	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—KRAS—bile duct cancer	4.57e-05	0.000492	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—EGFR—bile duct cancer	4.56e-05	0.00049	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—TGFB1—bile duct cancer	4.55e-05	0.00049	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	4.54e-05	0.000489	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TGFBR2—bile duct cancer	4.52e-05	0.000486	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—IL6—bile duct cancer	4.51e-05	0.000485	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	4.47e-05	0.000481	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—EGFR—bile duct cancer	4.47e-05	0.000481	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TGFBR2—bile duct cancer	4.47e-05	0.000481	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—EGFR—bile duct cancer	4.46e-05	0.00048	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Selenium Micronutrient Network—IL6—bile duct cancer	4.43e-05	0.000477	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TP53—bile duct cancer	4.41e-05	0.000475	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—KRAS—bile duct cancer	4.41e-05	0.000474	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—EGFR—bile duct cancer	4.41e-05	0.000474	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RNF43—bile duct cancer	4.4e-05	0.000473	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	4.39e-05	0.000473	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Insulin Signaling—HRAS—bile duct cancer	4.39e-05	0.000472	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—GNAS—bile duct cancer	4.36e-05	0.000469	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—IDH2—bile duct cancer	4.33e-05	0.000466	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—NRAS—bile duct cancer	4.32e-05	0.000465	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—GNAS—bile duct cancer	4.31e-05	0.000464	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—SMAD4—bile duct cancer	4.28e-05	0.00046	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—ERBB2—bile duct cancer	4.27e-05	0.00046	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—bile duct cancer	4.24e-05	0.000457	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—EGFR—bile duct cancer	4.23e-05	0.000455	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—SMAD4—bile duct cancer	4.23e-05	0.000455	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—KRAS—bile duct cancer	4.22e-05	0.000454	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—KRAS—bile duct cancer	4.21e-05	0.000454	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—PTGS2—bile duct cancer	4.18e-05	0.000449	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—KRAS—bile duct cancer	4.16e-05	0.000448	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—RNF43—bile duct cancer	4.1e-05	0.000441	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—bile duct cancer	4.05e-05	0.000436	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TGFBR2—bile duct cancer	4.04e-05	0.000435	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TGFBR2—bile duct cancer	4.04e-05	0.000435	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—KRAS—bile duct cancer	4e-05	0.00043	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—EGFR—bile duct cancer	3.94e-05	0.000424	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—GNAS—bile duct cancer	3.9e-05	0.000419	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—GNAS—bile duct cancer	3.9e-05	0.000419	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—HRAS—bile duct cancer	3.89e-05	0.000418	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—bile duct cancer	3.88e-05	0.000417	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—NRAS—bile duct cancer	3.83e-05	0.000413	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TP53—bile duct cancer	3.83e-05	0.000412	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—SMAD4—bile duct cancer	3.82e-05	0.000412	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—SMAD4—bile duct cancer	3.82e-05	0.000412	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—NRAS—bile duct cancer	3.77e-05	0.000406	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—HRAS—bile duct cancer	3.75e-05	0.000403	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—KRAS—bile duct cancer	3.72e-05	0.000401	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—IDH1—bile duct cancer	3.72e-05	0.0004	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—ERBB2—bile duct cancer	3.7e-05	0.000399	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—HRAS—bile duct cancer	3.59e-05	0.000386	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—IL6—bile duct cancer	3.58e-05	0.000386	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—HRAS—bile duct cancer	3.58e-05	0.000386	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—HRAS—bile duct cancer	3.54e-05	0.000381	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IDH1—bile duct cancer	3.53e-05	0.00038	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—IL6—bile duct cancer	3.5e-05	0.000377	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—PTGS2—bile duct cancer	3.5e-05	0.000376	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—EGFR—bile duct cancer	3.43e-05	0.00037	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—IL6—bile duct cancer	3.43e-05	0.00037	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—IDH2—bile duct cancer	3.43e-05	0.00037	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—IL6—bile duct cancer	3.43e-05	0.000369	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HRAS—bile duct cancer	3.4e-05	0.000366	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—IL6—bile duct cancer	3.39e-05	0.000365	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.37e-05	0.000362	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—ERBB2—bile duct cancer	3.31e-05	0.000356	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—KRAS—bile duct cancer	3.3e-05	0.000355	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—NRAS—bile duct cancer	3.25e-05	0.00035	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—KRAS—bile duct cancer	3.24e-05	0.000349	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	3.17e-05	0.000341	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—HRAS—bile duct cancer	3.16e-05	0.00034	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	3.16e-05	0.00034	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	3.1e-05	0.000334	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	3.1e-05	0.000334	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—IL6—bile duct cancer	3.03e-05	0.000326	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—GNAS—bile duct cancer	3.02e-05	0.000325	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—TGFB1—bile duct cancer	3.02e-05	0.000325	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—ERBB2—bile duct cancer	2.99e-05	0.000322	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—EGFR—bile duct cancer	2.96e-05	0.000319	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—IDH1—bile duct cancer	2.95e-05	0.000318	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	2.95e-05	0.000317	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	2.93e-05	0.000315	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HGF—bile duct cancer	2.88e-05	0.00031	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HGF—bile duct cancer	2.86e-05	0.000307	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—ERBB2—bile duct cancer	2.83e-05	0.000304	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—NRAS—bile duct cancer	2.82e-05	0.000303	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HRAS—bile duct cancer	2.81e-05	0.000302	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—KRAS—bile duct cancer	2.8e-05	0.000301	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—IDH2—bile duct cancer	2.79e-05	0.000301	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—IDH2—bile duct cancer	2.78e-05	0.000299	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—HRAS—bile duct cancer	2.76e-05	0.000297	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—NRAS—bile duct cancer	2.76e-05	0.000297	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—NRAS—bile duct cancer	2.76e-05	0.000297	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—ERBB2—bile duct cancer	2.71e-05	0.000292	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL6—bile duct cancer	2.68e-05	0.000289	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—IL6—bile duct cancer	2.64e-05	0.000284	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.62e-05	0.000281	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	2.6e-05	0.00028	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—EGFR—bile duct cancer	2.57e-05	0.000276	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MMP9—bile duct cancer	2.56e-05	0.000276	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—NRAS—bile duct cancer	2.52e-05	0.000271	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—EGFR—bile duct cancer	2.51e-05	0.00027	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—EGFR—bile duct cancer	2.51e-05	0.00027	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—IDH2—bile duct cancer	2.49e-05	0.000268	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—SLC5A5—bile duct cancer	2.45e-05	0.000264	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—IDH2—bile duct cancer	2.43e-05	0.000262	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—KRAS—bile duct cancer	2.42e-05	0.000261	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—IDH1—bile duct cancer	2.4e-05	0.000259	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—ERBB2—bile duct cancer	2.39e-05	0.000258	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—IDH1—bile duct cancer	2.39e-05	0.000257	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—HRAS—bile duct cancer	2.38e-05	0.000256	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—KRAS—bile duct cancer	2.37e-05	0.000255	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—KRAS—bile duct cancer	2.37e-05	0.000255	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—ERBB2—bile duct cancer	2.37e-05	0.000255	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.3e-05	0.000248	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—EGFR—bile duct cancer	2.29e-05	0.000247	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.29e-05	0.000247	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	2.28e-05	0.000245	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NRAS—bile duct cancer	2.27e-05	0.000245	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—IL6—bile duct cancer	2.27e-05	0.000245	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—IDH2—bile duct cancer	2.27e-05	0.000245	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	2.24e-05	0.000241	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NOS2—bile duct cancer	2.21e-05	0.000237	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	2.2e-05	0.000236	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—KRAS—bile duct cancer	2.17e-05	0.000233	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—NRAS—bile duct cancer	2.15e-05	0.000231	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—IDH1—bile duct cancer	2.14e-05	0.000231	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—ERBB2—bile duct cancer	2.14e-05	0.00023	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—ERBB2—bile duct cancer	2.14e-05	0.00023	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TGFB1—bile duct cancer	2.11e-05	0.000228	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—IDH1—bile duct cancer	2.09e-05	0.000225	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	2.08e-05	0.000223	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—EGFR—bile duct cancer	2.07e-05	0.000223	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—NRAS—bile duct cancer	2.06e-05	0.000222	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HRAS—bile duct cancer	2.06e-05	0.000222	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MMP9—bile duct cancer	2.05e-05	0.000221	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MMP9—bile duct cancer	2.03e-05	0.000218	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—HRAS—bile duct cancer	2.02e-05	0.000217	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—HRAS—bile duct cancer	2.02e-05	0.000217	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TGFBR2—bile duct cancer	2.01e-05	0.000216	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL6—bile duct cancer	1.97e-05	0.000212	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—EGFR—bile duct cancer	1.96e-05	0.000211	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—KRAS—bile duct cancer	1.96e-05	0.000211	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—IDH1—bile duct cancer	1.96e-05	0.000211	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—SLC5A5—bile duct cancer	1.95e-05	0.00021	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GNAS—bile duct cancer	1.94e-05	0.000209	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL6—bile duct cancer	1.93e-05	0.000208	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL6—bile duct cancer	1.93e-05	0.000208	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GNAS—bile duct cancer	1.91e-05	0.000205	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SMAD4—bile duct cancer	1.9e-05	0.000205	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—EGFR—bile duct cancer	1.88e-05	0.000202	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TGFBR2—bile duct cancer	1.87e-05	0.000202	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—KRAS—bile duct cancer	1.85e-05	0.000199	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	1.84e-05	0.000199	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HRAS—bile duct cancer	1.84e-05	0.000198	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MMP9—bile duct cancer	1.84e-05	0.000198	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MMP9—bile duct cancer	1.84e-05	0.000198	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NRAS—bile duct cancer	1.82e-05	0.000196	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NRAS—bile duct cancer	1.8e-05	0.000194	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—KRAS—bile duct cancer	1.78e-05	0.000191	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SMAD4—bile duct cancer	1.77e-05	0.000191	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL6—bile duct cancer	1.76e-05	0.00019	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—bile duct cancer	1.74e-05	0.000187	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TGFB1—bile duct cancer	1.69e-05	0.000182	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TGFB1—bile duct cancer	1.67e-05	0.00018	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HRAS—bile duct cancer	1.66e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EGFR—bile duct cancer	1.66e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ERBB2—bile duct cancer	1.65e-05	0.000177	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EGFR—bile duct cancer	1.64e-05	0.000177	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NRAS—bile duct cancer	1.63e-05	0.000175	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NRAS—bile duct cancer	1.63e-05	0.000175	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL6—bile duct cancer	1.59e-05	0.000171	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SLC5A5—bile duct cancer	1.59e-05	0.000171	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SLC5A5—bile duct cancer	1.58e-05	0.00017	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HRAS—bile duct cancer	1.57e-05	0.000169	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—KRAS—bile duct cancer	1.57e-05	0.000169	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—KRAS—bile duct cancer	1.55e-05	0.000167	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GNAS—bile duct cancer	1.51e-05	0.000163	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TGFB1—bile duct cancer	1.51e-05	0.000163	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TGFB1—bile duct cancer	1.51e-05	0.000163	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HRAS—bile duct cancer	1.51e-05	0.000163	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IL6—bile duct cancer	1.51e-05	0.000162	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.49e-05	0.00016	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EGFR—bile duct cancer	1.48e-05	0.00016	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EGFR—bile duct cancer	1.48e-05	0.00016	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.48e-05	0.000159	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SLC5A5—bile duct cancer	1.42e-05	0.000152	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KRAS—bile duct cancer	1.4e-05	0.000151	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KRAS—bile duct cancer	1.4e-05	0.000151	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—bile duct cancer	1.39e-05	0.00015	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SLC5A5—bile duct cancer	1.38e-05	0.000149	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HRAS—bile duct cancer	1.33e-05	0.000143	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.33e-05	0.000143	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS2—bile duct cancer	1.32e-05	0.000142	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HRAS—bile duct cancer	1.32e-05	0.000142	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SLC5A5—bile duct cancer	1.29e-05	0.000139	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—bile duct cancer	1.28e-05	0.000137	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NRAS—bile duct cancer	1.26e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—bile duct cancer	1.26e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NRAS—bile duct cancer	1.25e-05	0.000135	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—bile duct cancer	1.25e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—bile duct cancer	1.25e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GNAS—bile duct cancer	1.23e-05	0.000133	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GNAS—bile duct cancer	1.22e-05	0.000132	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.21e-05	0.00013	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HRAS—bile duct cancer	1.19e-05	0.000128	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HRAS—bile duct cancer	1.19e-05	0.000128	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TGFB1—bile duct cancer	1.17e-05	0.000126	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EGFR—bile duct cancer	1.14e-05	0.000123	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—bile duct cancer	1.14e-05	0.000123	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—bile duct cancer	1.14e-05	0.000123	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GNAS—bile duct cancer	1.1e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—KRAS—bile duct cancer	1.09e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KRAS—bile duct cancer	1.08e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GNAS—bile duct cancer	1.07e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB2—bile duct cancer	1.06e-05	0.000115	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—bile duct cancer	1.02e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GNAS—bile duct cancer	1e-05	0.000108	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB2—bile duct cancer	9.93e-06	0.000107	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—bile duct cancer	9.66e-06	0.000104	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HRAS—bile duct cancer	9.23e-06	9.94e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HRAS—bile duct cancer	9.16e-06	9.86e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MMP9—bile duct cancer	9.13e-06	9.83e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—bile duct cancer	8.77e-06	9.44e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NRAS—bile duct cancer	8.1e-06	8.72e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NRAS—bile duct cancer	7.55e-06	8.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TGFB1—bile duct cancer	7.52e-06	8.1e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGFR—bile duct cancer	7.38e-06	7.94e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TGFB1—bile duct cancer	7.02e-06	7.56e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KRAS—bile duct cancer	6.97e-06	7.5e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGFR—bile duct cancer	6.88e-06	7.41e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—bile duct cancer	6.62e-06	7.12e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—bile duct cancer	6.58e-06	7.08e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KRAS—bile duct cancer	6.5e-06	7e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—bile duct cancer	6.19e-06	6.67e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HRAS—bile duct cancer	5.92e-06	6.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—bile duct cancer	5.91e-06	6.36e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—bile duct cancer	5.76e-06	6.2e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—bile duct cancer	5.67e-06	6.1e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HRAS—bile duct cancer	5.53e-06	5.95e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—bile duct cancer	5.38e-06	5.8e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—bile duct cancer	5.29e-06	5.69e-05	CbGpPWpGaD
